The definition of the role of positron emission tomography (PET) in peripheral T-cell lymphomas (PTCLs) is still under investigation. The purpose of the present observational retrospective study was to assess the early prognostic value of PET after the first three cycles of therapy (PET+3), evaluating visual data in de novo PTCL patients treated in first line with standard chemotherapy and followed by both PET and computed tomography scan. Of 27 PET+3-negative patients, 19 also had a negative PET at the end of treatment (PET+6), whereas 8 of 27 had a positive final one; 6 of 7 PET+3-positive patients had a positive PET+6, whereas only 1 patient had a negative PET+6. Estimated overall survival plotted according to PET+3 results showed 78.6\% for negative patients and 21.4\% for positive patients at 88.7 months with a significant difference. Patients with negative PET+3 had superior progression-free survival of 72.6\% compared with 16.7\% of PET+3-positive patients. At the time of this analysis, 17 of 19 (89.5\%) patients with negative PET+3 are in continuous complete response (CCR) and only 1 of 7 (14.2\%) patients with positive PET+3 is still in CCR. In conclusion, our results indicate that positive PET+3 is predictive of a worse outcome in PTCL, and this significant statistical difference between the two curves could be clinically informative. Larger and prospective studies and harmonization of PET reading criteria are needed.

Pellegrini Cinzia, A.L. (2014). Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. THE ONCOLOGIST, 19, 746-750 [10.1634/theoncologist.2013-0463].

Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

Pellegrini Cinzia;Argnani Lisa;Broccoli Alessandro;Stefoni Vittorio;Derenzini Enrico;Gandolfi Letizia;Casadei Beatrice;Maglie Roberto;Pileri Stefano;Zinzani Pier Luigi.
2014

Abstract

The definition of the role of positron emission tomography (PET) in peripheral T-cell lymphomas (PTCLs) is still under investigation. The purpose of the present observational retrospective study was to assess the early prognostic value of PET after the first three cycles of therapy (PET+3), evaluating visual data in de novo PTCL patients treated in first line with standard chemotherapy and followed by both PET and computed tomography scan. Of 27 PET+3-negative patients, 19 also had a negative PET at the end of treatment (PET+6), whereas 8 of 27 had a positive final one; 6 of 7 PET+3-positive patients had a positive PET+6, whereas only 1 patient had a negative PET+6. Estimated overall survival plotted according to PET+3 results showed 78.6\% for negative patients and 21.4\% for positive patients at 88.7 months with a significant difference. Patients with negative PET+3 had superior progression-free survival of 72.6\% compared with 16.7\% of PET+3-positive patients. At the time of this analysis, 17 of 19 (89.5\%) patients with negative PET+3 are in continuous complete response (CCR) and only 1 of 7 (14.2\%) patients with positive PET+3 is still in CCR. In conclusion, our results indicate that positive PET+3 is predictive of a worse outcome in PTCL, and this significant statistical difference between the two curves could be clinically informative. Larger and prospective studies and harmonization of PET reading criteria are needed.
2014
Pellegrini Cinzia, A.L. (2014). Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. THE ONCOLOGIST, 19, 746-750 [10.1634/theoncologist.2013-0463].
Pellegrini Cinzia, Argnani Lisa, Broccoli Alessandro, Stefoni Vittorio, Derenzini Enrico, Gandolfi Letizia, Casadei Beatrice, Maglie Roberto, Pileri S...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/506393
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact